GQ Bio to Discuss Its AI Approach for Capsid Engineering of Gene Therapy Vectors

GQ Bio’s CEO Kilian Guse and head of bioinformatics Brian Dawson will present the company’s AI approach for capsid engineering of GQ Bio’s gene therapy vector technology at the FoldForum in Hamburg, Germany on April 24, 2024 and discuss it with other AI expert in the field.

GQ Bio will present its capsid engineering platform, which aims to generate tissue-specific high-capacity vectors (HCAd) to develop targeted gene therapeutics. Various bioinformatics and AI technologies are used for this capsid engineering platform.

The FoldForum is a collaborative event on deeptech in protein science organized by AUFBRUCH.Hamburg and the Artificial Intelligence Center Hamburg (Aric e.V.).